Skip to main content

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Shah, MH; Goldner, WS; Benson, AB; Bergsland, E; Blaszkowsky, LS; Brock, P; Chan, J; Das, S; Dickson, PV; Fanta, P; Giordano, T; Halperin, D ...
Published in: J Natl Compr Canc Netw
July 28, 2021

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia. NETs are generally subclassified by site of origin, stage, and histologic characteristics. Appropriate diagnosis and treatment of NETs often involves collaboration between specialists in multiple disciplines, using specific biochemical, radiologic, and surgical methods. Specialists include pathologists, endocrinologists, radiologists (including nuclear medicine specialists), and medical, radiation, and surgical oncologists. These guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine and adrenal tumors and are intended to assist with clinical decision-making. This article is focused on the 2021 NCCN Guidelines principles of genetic risk assessment and counseling and recommendations for well-differentiated grade 3 NETs, poorly differentiated neuroendocrine carcinomas, adrenal tumors, pheochromocytomas, and paragangliomas.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

July 28, 2021

Volume

19

Issue

7

Start / End Page

839 / 868

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neuroendocrine Tumors
  • Medical Oncology
  • Humans
  • Adrenal Gland Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., … Hochstetler, C. (2021). Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 19(7), 839–868. https://doi.org/10.6004/jnccn.2021.0032
Shah, Manisha H., Whitney S. Goldner, Al B. Benson, Emily Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, Jennifer Chan, et al. “Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 19, no. 7 (July 28, 2021): 839–68. https://doi.org/10.6004/jnccn.2021.0032.
Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brock P, et al. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Jul 28;19(7):839–68.
Shah, Manisha H., et al. “Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 19, no. 7, July 2021, pp. 839–68. Pubmed, doi:10.6004/jnccn.2021.0032.
Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brock P, Chan J, Das S, Dickson PV, Fanta P, Giordano T, Halfdanarson TR, Halperin D, He J, Heaney A, Heslin MJ, Kandeel F, Kardan A, Khan SA, Kuvshinoff BW, Lieu C, Miller K, Pillarisetty VG, Reidy D, Salgado SA, Shaheen S, Soares HP, Soulen MC, Strosberg JR, Sussman CR, Trikalinos NA, Uboha NA, Vijayvergia N, Wong T, Lynn B, Hochstetler C. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Jul 28;19(7):839–868.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

July 28, 2021

Volume

19

Issue

7

Start / End Page

839 / 868

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neuroendocrine Tumors
  • Medical Oncology
  • Humans
  • Adrenal Gland Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis